NCT00503204View on ClinicalTrials.gov

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Recurrent GlioblastomaBrain Tumor

Interventions

DRUG

Cediranib

oral tablet

DRUG

Lomustine

oral capsule

Trial Locations (2)

Unknown

Research Site, Boston

Research Site, Sutton

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY